D H McDermott - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Lancet (London, England)|September 22, 1998

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)D H McDermott, P A Zimmerman, F Guignard, et al.

Genes and Immunity|October 19, 2001

Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1RA Sahagun-Ruiz, J S Colla, J Juhn, et al.

AIDS (London, England)|June 6, 2000

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapyT R O'Brien, D H McDermott, J P Ioannidis, et al.

Circulation Research|September 5, 2001

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosisD H McDermott, J P Halcox, W H Schenke, et al.

Virology|March 30, 2001

Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissueN Malkevitch, D H McDermott, Y Yi, et al.

Science (New York, N.Y.)|March 24, 2000

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1S Faure, L Meyer, D Costagliola, et al.

Blood|March 27, 2001

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseD Moatti, S Faure, F Fumeron, et al.

AIDS (London, England)|December 28, 2000

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort StudyD H McDermott, M J Beecroft, C A Kleeberger, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Lancet (London, England)|September 22, 1998

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)D H McDermott, P A Zimmerman, F Guignard, et al.

Genes and Immunity|October 19, 2001

Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1RA Sahagun-Ruiz, J S Colla, J Juhn, et al.

AIDS (London, England)|June 6, 2000

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapyT R O'Brien, D H McDermott, J P Ioannidis, et al.

Circulation Research|September 5, 2001

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosisD H McDermott, J P Halcox, W H Schenke, et al.

Virology|March 30, 2001

Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissueN Malkevitch, D H McDermott, Y Yi, et al.

Science (New York, N.Y.)|March 24, 2000

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1S Faure, L Meyer, D Costagliola, et al.

Blood|March 27, 2001

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseD Moatti, S Faure, F Fumeron, et al.

AIDS (London, England)|December 28, 2000

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort StudyD H McDermott, M J Beecroft, C A Kleeberger, et al.

Pageof 1